| Literature DB >> 36148331 |
Chao-Lei Chen1, Jia-Bin Wang2, Yu-Qing Huang1, Ying-Qing Feng1.
Abstract
Background: Few studies have reported the association of early life exposure to famine with the risk of heart failure. The current study aimed to investigate whether exposure to famine in early life is associated with a higher risk of hospitalization for heart failure in adulthood.Entities:
Keywords: Chinese famine; diabetes; dyslipidemia; economic status; heart failure; hypertension
Year: 2022 PMID: 36148331 PMCID: PMC9485593 DOI: 10.3389/fpubh.2022.973753
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Flow chart of study participants. PEACE MPP, Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project.
Characteristics of study participants according to famine exposure among 36,212 participants.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Number | 36,212 | 12,542 | 10,493 | 13,177 | |
| Age, y | 57.4 (53.5–61.7) | 52.6 (51.6–53.7) | 57.2 (56.1–58.5) | 62.5 (61.4–63.5) | <0.001 |
| Men, | 13,570 (37.5) | 4,704 (37.5) | 3,655 (34.8) | 5,211 (39.5) | <0.001 |
| Educational status (high school or above), | 8,953 (24.7) | 2,976 (23.7) | 3,107 (29.6) | 2,870 (21.8) | <0.001 |
| Occupation (Farmer), | 5,202 (14.4) | 1,547 (12.3) | 1,516 (14.4) | 2,139 (16.2) | <0.001 |
| Economic status (annual income ≥50,000 yuan), | 15,899 (43.9) | 5,695 (45.4) | 4,574 (43.6) | 5,630 (42.7) | <0.001 |
| Marriage (married), | 33,096 (91.4) | 11,577 (92.3) | 9,585 (91.3) | 11,934 (90.6) | <0.001 |
| Current smoker, | 6,365 (17.6) | 2,101 (16.8) | 1,793 (17.1) | 2,471 (18.8) | <0.001 |
| Current drinker, | 2,010 (5.6) | 686 (5.5) | 535 (5.1) | 789 (6.0) | <0.001 |
| BMI, kg/m2 | 24.1 (22.0–26.3) | 24.2 (22.2–26.4) | 24.1 (22.1–26.3) | 23.9 (21.8–26.2) | <0.001 |
| Waist circumference, cm | 84.0 (78.0–90.0) | 84.0 (78.0–90.0) | 84.0 (78.0–90.0) | 85.0 (78.0–90.9) | <0.001 |
| SBP, mm Hg | 131.0 (119.5–143.5) | 127.5 (117.0–140.0) | 131.0 (119.5–144.0) | 133.5 (122.0–147.0) | <0.001 |
| DBP, mm Hg | 80.0 (72.5–87.5) | 79.5 (72.5–87.5) | 80.0 (72.5–87.5) | 80.0 (72.5–87.0) | 0.596 |
| FBG, mg/dL | 102.6 (91.8–115.2) | 100.8 (91.8–113.4) | 102.6 (91.8–115.2) | 102.6 (91.8–115.2) | <0.001 |
| TG, mg/dL | 122.1 (90.3–176.1) | 120.5 (88.6–172.8) | 124.9 (92.1–179.9) | 123.2 (92.1–177.2) | <0.001 |
| TC, mg/dL | 191.8 (162.5–223.9) | 189.6 (161.0–220.2) | 194.7 (164.9–227.2) | 192.7 (162.9–226.0) | <0.001 |
| LDL–C, mg/dL | 106.2 (82.2–133.2) | 104.5 (81.3–130.0) | 108.7 (84.0–137.0) | 106.8 (82.4–135.1) | <0.001 |
| HDL-C, mg/dL | 54.8 (44.8–67.6) | 55.0 (44.5–67.3) | 55.0 (44.9–67.7) | 55.7 (45.3–68.1) | <0.001 |
| Hypertension, | 16,385 (45.2) | 4,791 (38.2) | 4,796 (45.7) | 6,798 (51.6) | <0.001 |
| Diabetes, | 6,699 (18.5) | 2,025 (16.1) | 2,083 (19.9) | 2,591 (19.7) | <0.001 |
| Dyslipidemia, | 8,033 (22.2) | 2,349 (18.7) | 2,561 (24.4) | 3,123 (23.7) | <0.001 |
| Current use of antihypertensive drugs, | 7,942 (21.9) | 2,120 (16.9) | 2,324 (22.1) | 3,498 (26.5) | <0.001 |
| Current use of antidiabetic drugs, | 2,965 (8.2) | 764 (6.1) | 962 (9.2) | 1,239 (9.4) | <0.001 |
| Current use of lipid-lowering drugs, | 1,614 (4.5) | 396 (3.2) | 504 (4.8) | 714 (5.4) | <0.001 |
| Current use of statin therapy, | 275 (0.8) | 59 (0.5) | 90 (0.9) | 126 (1.0) | <0.001 |
| Current use of antiplatelet drugs, | 197 (0.5) | 41 (0.3) | 47 (0.4) | 109 (0.8) | <0.001 |
Data are presented as median (IQR) for non-normally distributed variables, and numbers (percentages) for categorical variables. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.
Characteristics of study participants with or without hospitalization for heart failure among 36,121 participants.
|
|
|
|
|
|
|---|---|---|---|---|
| Number | 36,212 | 35,543 | 669 | |
| Age, y | 57.4 (53.5–61.7) | 57.3 (53.5–61.7) | 60.4 (56.5–62.7) | <0.001 |
| Men, | 13,570 (37.5) | 13,182 (37.1) | 388 (58.0) | <0.001 |
| Educational status (high school or above), | 8,953 (24.7) | 8,783 (24.7) | 170 (25.4) | 0.71 |
| Occupation (Farmer), | 5,202 (14.4) | 5,102 (14.4) | 100 (14.9) | 0.71 |
| Economic status (annual income ≥ 50,000 yuan), | 15,899 (43.9) | 15,605 (43.9) | 294 (43.9) | 0.99 |
| Marriage (married), | 33,096 (91.4) | 32,487 (91.4) | 609 (91.0) | 0.79 |
| Current smoker, | 6,365 (17.6) | 6,170 (17.4) | 195 (29.1) | <0.001 |
| Current drinker, | 2,010 (5.6) | 1,962 (5.5) | 48 (7.2) | 0.08 |
| BMI, kg/m2 | 24.1 (22.0–26.3) | 24.1 (22.0–26.3) | 24.9 (22.6–27.2) | <0.001 |
| Waist circumference, cm | 84.0 (78.0–90.0) | 84.0 (78.0–90.0) | 88.0 (80.0–94.0) | <0.001 |
| SBP, mm Hg | 131.0 (119.5–143.5) | 131.0 (119.5–143.5) | 135.0 (122.0–151.5) | <0.001 |
| DBP, mm Hg | 80.0 (72.5–87.5) | 80.0 (72.5–87.5) | 81.0 (73.0–89.0) | 0.009 |
| FBG, mg/dL | 102.6 (91.8–115.2) | 101.2 (91.8–115.2) | 106.2 (91.8–127.8) | <0.001 |
| TG, mg/dL | 122.4 (90.5–176.5) | 122.4 (90.5–176.5) | 128.6 (94.0–190.7) | 0.008 |
| TC, mg/dL | 192.3 (162.9–224.5) | 192.3 (163.3–224.5) | 174.5 (142.8–214.4) | <0.001 |
| LDL-C, mg/dL | 109.9 (84.4–131.2) | 110.3 (84.4–131.6) | 98.7 (72.4–122.3) | <0.001 |
| HDL-C, mg/dL | 55.0 (44.9–67.7) | 55.3 (44.9–67.7) | 49.5 (40.6–61.9) | <0.001 |
| Hypertension, | 16,385 (45.2) | 15,950 (44.9) | 435 (65.0) | <0.001 |
| Diabetes, | 6,699 (18.5) | 6,469 (18.2) | 230 (34.4) | <0.001 |
| Dyslipidemia, | 8,033 (22.2) | 7,838 (22.1) | 195 (29.1) | 0.009 |
| Current use of antihypertensive drugs, | 7,942 (21.9) | 7,639 (21.5) | 303 (45.3) | <0.001 |
| Current use of antidiabetic drugs, | 2,965 (8.2) | 2,829 (8.0) | 136 (20.3) | <0.001 |
| Current use of lipid-lowering drugs, | 1,614 (4.5) | 1,512 (4.3) | 102 (15.2) | 0.009 |
| Current use of statin therapy, | 275 (0.8) | 255 (0.7) | 20 (3.0) | <0.001 |
| Current use of antiplatelet drugs, | 197 (0.5) | 178 (0.5) | 19 (2.8) | <0.001 |
Data are presented as median (IQR) for non-normally distributed variables, and numbers (percentages) for categorical variables.
PEACE MPP, Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project; HF, heart failure; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.
Odds ratio with 95% CI of hospitalization for heart failure according to famine exposure among 36,212 participants.
|
|
|
| |
|---|---|---|---|
| Case (%) | 118 (0.9) | 211 (2.0) | 340 (2.6) |
| Model 1 | 1.0 | 2.13 (1.70–2.69) | 1.70 (1.12–2.59) |
| Model 2 | 1.0 | 2.14 (1.70–2.70) | 1.68 (1.11–2.56) |
| Model 3 | 1.0 | 1.96 (1.56–2.48) | 1.62 (1.07–2.47) |
Model 1: adjusted for age and sex.
Model 2: adjusted for age, sex, smoking, drinking, marriage, educational status, occupation, economic status, and body mass index.
Model 3: adjusted for age, sex, smoking, drinking, marriage, educational status, occupation, economic status, body mass index, hypertension, diabetes, dyslipidemia, statin therapy, and current use of antiplatelet drugs.
Figure 2Stratification analysis of associations of pre-famine and famine births with risk of hospitalization for heart failure compared with post-famine births. Presented were multivariable-adjusted generalized linear models with adjustment for age, sex, marriage, educational status, occupation, economic, smoking, drinking, body mass index, hypertension, diabetes, dyslipidemia, current use of antiplatelet medications, and statin therapy. The square in the middle represents the odds ratio of the risk estimation, and the bar represents its 95% CI.